Lv21
120 积分 2024-11-06 加入
Once-weekly semaglutide 2·4 mg in an Asian population with obesity, defined as BMI ≥25 kg/m2, in South Korea and Thailand (STEP 11): a randomised, double-blind, placebo-controlled, phase 3 trial
1小时前
待确认
A new model predicts the best medication for patients with type 2 diabetes mellitus
5个月前
已完结
Associations between metabolic syndrome and anxiety, and the mediating role of inflammation: Findings from the UK Biobank
10个月前
已完结
皖公网安备34019202002308
